Skip to main navigation Skip to search Skip to main content

Phase 1/2 Clinical Trial of Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Project: Research

Project Details

StatusActive
Effective start/end date04/17/26 → 04/16/27

Funding

  • ImmunityBio Incorporated: $36,000.00